Given that FTO polymorphism is associated with various human metabolic diseases, including obesity, diabetes, and cardiovascular disease [88,89], it will be interesting to study how FTO and NADPH-dependent m6A demethylation contributes to metabolic processes in normal and pathological conditions. This evidence concerns the gene FTO and obesity due to melanocortin 4 receptor deficiency.